Ubs Group Ag Semler Scientific, Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Semler Scientific, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 52,033 shares of SMLR stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,033

Previous 119,807 56.57%

Holding current value

$1.5 Million

Previous $6.47 Million 70.89%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$32.62 - $64.94 $2.21 Million - $4.4 Million	-67,774 Reduced 56.57%	52,033 $1.88 Million
Q4 2024 Feb 14, 2025	BUY	$22.48 - $74.73 $2.6 Million - $8.63 Million	115,481 Added 2669.46%	119,807 $6.47 Million
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.21 $59,987 - $97,404	2,690 Added 164.43%	4,326 $101,000
Q2 2024 Aug 13, 2024	SELL	$21.03 - $40.57 $148,913 - $287,276	-7,081 Reduced 81.23%	1,636 $56,000
Q1 2024 May 13, 2024	BUY	$28.42 - $51.54 $39,645 - $71,898	1,395 Added 19.05%	8,717 $254,000
Q4 2023 Feb 09, 2024	BUY	$25.66 - $46.29 $123,758 - $223,256	4,823 Added 193.0%	7,322 $324,000
Q3 2023 Nov 09, 2023	SELL	$23.15 - $28.54 $17,524 - $21,604	-757 Reduced 23.25%	2,499 $63,000
Q2 2023 Aug 11, 2023	BUY	$22.5 - $30.58 $66,487 - $90,363	2,955 Added 981.73%	3,256 $85,000
Q1 2023 May 12, 2023	BUY	$19.28 - $41.74 $3,875 - $8,389	201 Added 201.0%	301 $8,000
Q4 2022 Feb 08, 2023	SELL	$28.01 - $43.49 $60,893 - $94,547	-2,174 Reduced 95.6%	100 $3,000
Q3 2022 Nov 10, 2022	BUY	$27.75 - $45.8 $56,748 - $93,661	2,045 Added 893.01%	2,274 $85,000
Q2 2022 Aug 10, 2022	BUY	$27.86 - $50.32 $6,379 - $11,523	229 New	229 $6,000

Others Institutions Holding SMLR

# of Institutions

140

Shares Held

6.76M

Call Options Held

256K

Put Options Held

123K

View Full List

About Semler Scientific, Inc.

Ticker SMLR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,800,580
Market Cap $196M
Description
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...

More about SMLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account